# Scholar Rock Holding share price today (Scholar Rock Holding Corporation, SRRK)

> Scholar Rock Holding Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. SRRK · Healthcare · Biotechnology · data as of 5 November 2026. Page: https://www.sectoralpha.in/us/stocks/srrk

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $45.50 (+57.2% in a year)
- Revenue (Mar 2022): $33.2 M
- Profit (Mar 2022): −$8.0 M
- Operating margin: −20.9%
- ROE: −52%, FY22
- ROIC: −67.5%, against a 8.4% cost of capital: −75.9 points

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Scholar Rock Holding share price today? Scholar Rock Holding Corporation's share price was $45.50 at the close on 5 November 2026. It has been moving sideways for 6 weeks. That is 5.6% below its average price over the last 200 trading days. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 8 weeks running. In the last 52 weeks it traded between $29 and $58, and at that close it sat 57% of the way up from that low. Over the last 8.4 years the share price moved +203% while the S&P 500 moved +169%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 11 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Scholar Rock Holding pay? Scholar Rock Holding Corporation pays no dividend. In the last 4 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Scholar Rock Holding on? Scholar Rock Holding is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Scholar Rock Holding profitable? Scholar Rock Holding Corporation posted a net loss of $8.0 M in the Mar 2022 quarter. The full FY22 year was a loss of $135 M. That loss is 24.0% of the quarter's revenue. ## How much revenue does Scholar Rock Holding make, and is it growing? Scholar Rock Holding Corporation reported $33.2 M of revenue in the Mar 2022 quarter. Over 1 years it has grown 76.4% a year on average. The last full year, FY22, came in at $33.2 M. The last four reported quarters add to $47.3 M. ## How much of every $100 of sales does Scholar Rock Holding keep? Scholar Rock Holding Corporation's operating margin was −20.9% in the Mar 2022 quarter. Across 2 years it has been between −690.5% and −399.1%. Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## Is Scholar Rock Holding's profit turning into cash? Scholar Rock Holding Corporation's cash-flow history is too short to judge how much of its profit turns into cash. In FY22 its operations used $133 M of cash, against −$135 M of profit. After $1.1 M of spending on assets, free cash was −$134 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Scholar Rock Holding's cash go? Scholar Rock Holding Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $6.3 M on assets over the last 2 years. Averaged over those years that is 9.5% of FY22 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $6.3 M over the last 2 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Scholar Rock Holding's P/E ratio, and how does it compare with its own history? Scholar Rock Holding Corporation has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Scholar Rock Holding Corporation at 166.9× its FY22 revenue of $33.2 M. The P/E comes back here once profit turns positive. ## Is the Scholar Rock Holding business getting better or worse? Scholar Rock Holding Corporation's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. Why it matters: with too little history, we say so rather than guess a direction. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Scholar Rock Holding earn on its capital? Scholar Rock Holding Corporation earned a ROE of −52% in FY22. Its return on capital used (ROIC) is 75.9 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −405.2% net margin and 0.09× asset turnover (sales divided by assets). Why the return is what it is (FY22): a −405.2% net margin × 0.09× asset turnover × 1.38× leverage (assets divided by equity) ≈ −50.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −67.5% − 8.4% = −75.9 percentage points. The 8.4% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Scholar Rock Holding have too much debt? Scholar Rock Holding Corporation has total debt of $204 M against shareholder equity of $254 M as of Jun 2026, so its debt is 0.80× its equity. Year by year, that ratio went from 0.45 in FY21 to 0.44 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Scholar Rock Holding shareholding pattern? 21.4% of Scholar Rock Holding Corporation's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 9.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Scholar Rock Holding from balance-sheet trouble? For Scholar Rock Holding Corporation, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Scholar Rock Holding rank in its industry? There is no score against its industry: Scholar Rock Holding Corporation is not among the largest members shown in this industry comparison for Biotechnology. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Scholar Rock Holding compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Scholar Rock Holding in size? Scholar Rock Holding is the 42nd largest of 211 Biotechnology companies on Sector Alpha by market value (scores of 5 November 2026). Just above it: Mirum Pharmaceuticals, Inc., Ligand Pharmaceuticals Incorporated and CG Oncology, Inc. Just below it: PTC Therapeutics, Inc., CRISPR Therapeutics AG and Travere Therapeutics, Inc. ### Biotechnology companies close in size

1. [Mirum Pharmaceuticals, Inc.](https://www.sectoralpha.in/us/stocks/mirm) $6.1 billion
2. [Ligand Pharmaceuticals Incorporated](https://www.sectoralpha.in/us/stocks/lgnd) $6 billion
3. [CG Oncology, Inc.](https://www.sectoralpha.in/us/stocks/cgon) $5.7 billion
4. Scholar Rock Holding Corporation $5.5 billion
5. [PTC Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/ptct) $5.5 billion
6. [CRISPR Therapeutics AG](https://www.sectoralpha.in/us/stocks/crsp) $4.7 billion
7. [Travere Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/tvtx) $4.7 billion

[All 211 Biotechnology companies, largest first](https://www.sectoralpha.in/us/sectors/biotechnology#all-companies)

### Companies close in size in other industries

1. [SSR Mining Inc.](https://www.sectoralpha.in/us/stocks/ssrm) $5.6 billion · Gold
2. [Bank OZK](https://www.sectoralpha.in/us/stocks/ozk) $5.6 billion · Banks - Regional
3. Scholar Rock Holding Corporation $5.6 billion
4. [Varonis Systems, Inc.](https://www.sectoralpha.in/us/stocks/vrns) $5.6 billion · Software - Infrastructure
5. [White Mountains Insurance Group, Ltd.](https://www.sectoralpha.in/us/stocks/wtm) $5.6 billion · Insurance - Property & Casualty

## What else do people ask about Scholar Rock Holding? ### What were Scholar Rock Holding's latest quarterly results? Scholar Rock Holding Corporation reported revenue of $33.2 M and a net loss of $8.0 M for the Mar 2022 quarter. Earnings per share were −$0.21. The operating margin was −20.9% (as of 5 November 2026). ### What is Scholar Rock Holding's market cap? Scholar Rock Holding Corporation's market capitalisation is $5.5 B at a stock price of $45.50. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 5 November 2026). ### How is Scholar Rock Holding performing? Scholar Rock Holding Corporation's share price has been moving sideways for 6 weeks. Over the past 13 weeks it has done worse than the S&P 500, for 8 weeks running. This describes what the data did, not a rating (as of 5 November 2026). ### Will Scholar Rock Holding's stock price go up? This page does not forecast Scholar Rock Holding Corporation's stock price. What it shows instead: the stock price is $45.50, and it has been moving sideways for 6 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 5 November 2026). ### Where is Scholar Rock Holding in its business cycle? Scholar Rock Holding Corporation's FY22 operating margin was −399.1%, against a 2-year range of −690.5% to −399.1%: the middle of its own range, neither a peak nor a low. The latest quarter was −20.9%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 5 November 2026). ### What could break the Scholar Rock Holding story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 5 November 2026). ### Is Scholar Rock Holding a stock worth studying right now? What the numbers show: Scholar Rock Holding Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 5 November 2026). This is research, not advice. We’re not SEBI-registered.